{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:56:10Z","timestamp":1776318970575,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early-stage lung adenocarcinoma (LUAD) patients with similar pathological stage exhibit heterogeneous recurrence risk. Prior work suggested that intra-tumoral immune composition, particularly B cells, regulatory T cells, and macrophages stratify recurrence outcomes. These immune programs operate in the context of stromal and tumor-intrinsic transcriptomic programs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify coordinated gene expression programs linking immune, stromal and tumor-intrinsic processes to recurrence in early-stage (IA\/IB) LUAD, and to assess their prognostic relevance in an independent cohort using overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Gene expression data of 292 patients in NCBI GEO datasets was reanalyzed and unsupervised clusters were identified within the differentially expressed genes (DEGs) that associated with recurrence. Protective and risk-associated genes were identified in covariate-adjusted Cox models. GO enrichment was performed using DEGs. Pathway-level principal component scores were tested for association with overall survival in TCGA-LUAD early-stage, treatment-naive patients (n=90).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Modules enriched for B-cell and antibody responses, vascular homeostasis, and regulation of fibrotic remodeling were associated with reduced recurrence, whereas those enriched for epithelial organization and extracellular matrix (ECM) remodeling conferred increased risk. The contrast between ECM-driven recurrence risk and protective immune programs may reflect distinct biological states associated with recurrence timing, wherein changes in the ECM precede impaired lymphocyte responses in early-stage disease. In the TCGA cohort, immune-related programs associated with improved survival, whereas extracellular matrix (ECM) and epithelial differentiation\/proliferation programs associated with worse survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>This study integrates immune, tumor, and stromal transcriptional programs to identify a prognostic dichotomy between ECM remodeling and adaptive immune-supportive states in early-stage LUAD. These coordinated tumor states and immune-matrix interactions offer mechanistic insight into recurrence and provide a framework for risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1762224","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:26:07Z","timestamp":1776317167000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Divergent immune and extracellular matrix transcriptional programs underlie poor prognosis in early-stage lung adenocarcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Jyothi Thyagabhavan","family":"Mony","sequence":"first","affiliation":[{"name":"Independent researcher","place":["San Diego, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jtcvs.2024.05.009","article-title":"High-risk features associated with recurrence in stage I lung adenocarcinoma","volume":"169","author":"Fick","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1442-0","article-title":"Local and systemic recurrence is the achilles heel of cancer surgery","volume":"18","author":"Aliperti","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201409-1671PP","article-title":"The non-small cell lung cancer immune contexture: A major determinant of tumor characteristics and patient outcome","volume":"191","author":"Remark","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1476365","article-title":"Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis","volume":"15","author":"Yan","year":"2024","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18710","DOI":"10.1038\/s41598-023-42851-2","article-title":"Prognosis of recurrence after complete resection in early-stage lung adenocarcinoma based on molecular alterations: a systematic review and meta-analysis","volume":"13","author":"Zhou","year":"2023","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02298","article-title":"Prognostic implications of heterogeneity in intra-tumoral immune composition for recurrence in early stage lung cancer","volume":"9","author":"Mony","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/nejmoa2302983","article-title":"Perioperative pembrolizumab for early-stage non\u2013small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v13.i9.758","article-title":"Neoadjuvant immunotherapy in non-small-cell lung cancer: times are changing\u2014and fast","volume":"13","author":"Aguado","year":"2022","journal-title":"World J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty410","article-title":"Using meshes for MeSH term enrichment and semantic analyses","volume":"34","author":"Yu","year":"2018","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1746554","article-title":"CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer","volume":"9","author":"Yoshimura","year":"2020","journal-title":"Oncoimmunology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00018-024-05268-2","article-title":"CD200R activation on na\u00efve T cells by B cells induces suppressive activity of T cells via IL-24","volume":"81","author":"Chu","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000189","article-title":"CD200 promotes immunosuppression in the pancreatic tumor microenvironment","volume":"8","author":"Choueiry","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60456-3","article-title":"CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRP\u03b1-CD47 to suppress tumor growth","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.316062","article-title":"CD200 limits monopoiesis and monocyte recruitment in atherosclerosis","volume":"129","author":"Kassiteridi","year":"2021","journal-title":"Circ Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00129","article-title":"Alterations in CD200-CD200R1 system during EAE already manifest at presymptomatic stages","volume":"11","author":"Valente","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1637","article-title":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection","volume":"9","author":"Snelgrove","year":"2008","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-015-0261-z","article-title":"Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis","volume":"16","author":"Kobayashi","year":"2015","journal-title":"Respir Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.immuni.2013.10.022","article-title":"Interleukin-6 signaling drives fibrosis in unresolved inflammation","volume":"40","author":"Fielding","year":"2014","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.545822","article-title":"Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-\u03b2 (TGF-\u03b2) signaling promoting SMAD3 activation and fibrosis via Gremlin protein","volume":"289","author":"O\u2019Reilly","year":"2014","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100052","article-title":"M2 macrophage co-culture overrides viscoelastic hydrogel mechanics to promote IL-6-dependent fibroblast activation","volume":"1","author":"Astrab","year":"2025","journal-title":"Cell Biomaterials"},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tranon.2015.02.002","article-title":"Lung adenocarcinomas and lung cancer cell lines show association of MMP-1 expression with STAT3 activation","volume":"8","author":"Sch\u00fctz","year":"2015","journal-title":"Transl Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5825","article-title":"Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3\/MMP-13 up-regulation","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.omto.2019.03.012","article-title":"Matrix metalloproteinase 11 is a potential therapeutic target in lung adenocarcinoma","volume":"14","author":"Yang","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5917506","article-title":"Comprehensive analysis of the immune and prognostic implication of MMP14 in lung cancer","volume":"2021","author":"Zheng","year":"2021","journal-title":"Dis Markers"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117178","article-title":"Emerging role of BMPs\/BMPR2 signaling pathway in treatment for pulmonary fibrosis","volume":"178","author":"Ye","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41374-018-0069-9","article-title":"BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-\u03b21 signaling","volume":"98","author":"Chung","year":"2018","journal-title":"Lab Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.jid.2019.02.020","article-title":"Bone morphogenetic protein-6 inhibits fibrogenesis in scleroderma offering treatment options for fibrotic skin disease","volume":"139","author":"Arndt","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2102307","DOI":"10.1183\/13993003.02307-2021","article-title":"Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts","volume":"60","author":"Guan","year":"2022","journal-title":"Eur Respir J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s1535-6108(03)00240-x","article-title":"Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors","volume":"4","author":"Ruzinova","year":"2003","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13247","article-title":"Notch regulates BMP responsiveness and lateral branching in vessel networks via SMAD6","volume":"7","author":"Mouillesseaux","year":"2016","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Sci (1979)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1291530","article-title":"Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy","volume":"14","author":"Qian","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1762224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:26:08Z","timestamp":1776317168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1762224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1762224"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1762224","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1762224"}}